KIF20A and colorectal carcinoma: Additionally, KIF20A has been shown to promote proliferation of LUAD cells and mediate colorectal cancer (CRC) resistance to Oxaliplatin by inhibiting ferroptosis (Zhao et al., 2018; Yang C. et al., 2021).